Your browser doesn't support javascript.
loading
Diabetes remission and relapse following an intensive metabolic intervention combining insulin glargine/lixisenatide, metformin and lifestyle approaches: Results of a randomised controlled trial.
McInnes, Natalia; Hall, Stephanie; Lochnan, Heather A; Harris, Stewart B; Punthakee, Zubin; Sigal, Ronald J; Hramiak, Irene; Azharuddin, Mohammed; Liutkus, Joanne F; Yale, Jean-François; Sultan, Farah; Smith, Ada; Otto, Rose E; Sherifali, Diana; Liu, Yan Yun; Gerstein, Hertzel C.
  • McInnes N; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
  • Hall S; Population Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada.
  • Lochnan HA; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.
  • Harris SB; Population Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada.
  • Punthakee Z; Department of Medicine, The Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada.
  • Sigal RJ; Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
  • Hramiak I; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
  • Azharuddin M; Population Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada.
  • Liutkus JF; Departments of Medicine, Cardiac Sciences and Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Yale JF; Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
  • Sultan F; LMC Diabetes and Endocrinology, Burlington, Ontario, Canada.
  • Smith A; JF Liutkus Medicine Professional Corporation, Cambridge, Ontario, Canada.
  • Otto RE; McGill University, Quebec, Canada.
  • Sherifali D; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.
  • Liu YY; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
  • Gerstein HC; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Diabetes Obes Metab ; 25(11): 3347-3355, 2023 11.
Article en En | MEDLINE | ID: mdl-37580972

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Metformina Tipo de estudio: Clinical_trials / Etiology_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Metformina Tipo de estudio: Clinical_trials / Etiology_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article